Antibodies that specifically bind to TL5

Details Antibodies that specifically bind to TL5 Antibodies that specifically bind to TL5

2004-09-17

2009-06-02

Rawlings, Stephen L (Department: 1643)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S387100, C530S387300, C530S388220, C530S391300, C530S391700, C435S069100, C435S325000, C435S331000

Reexamination Certificate

active

07541441

ABSTRACT:
The present invention relates to antibodies and related molecules that specifically bind to TL5. Such antibodies have uses, for example, in the prevention and treatment of cancer as well as immune system diseases and disorders including autoimmune disease, rheumatoid arthritis, graft rejection, graft vs. host disease, and lymphadenopathy. The invention also relates to nucleic acid molecules encoding anti-TL5 antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention relates to methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially cancer as well as immune system diseases and disorders including autoimmune disease, rheumatoid arthritis, graft rejection, graft vs. host disease, and lymphadenopathy, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that specifically bind to TL5.

REFERENCES:
patent: 7138501 (2006-11-01), Ruben et al.
patent: 7220840 (2007-05-01), Ruben et al.
patent: WO 02/02641 (2002-01-01), None
patent: WO 03/089575 (2003-10-01), None
Mariuzza et al (Annu. Rev. Biophys. Biophys. Chem. 1987; 16: 139-159).
Rudikoff et al. (Proc. Natl. Acad. Sci. USA. 1982; 79 (6): 1979-1983).
Giusti et al. (Proc. Natl. Acad. Sci. USA. May 1987; 84 (9): 2926-2930).
Chien et al. (Proc. Natl. Acad. Sci. USA. Jul. 1989; 86 (14): 5532-5536).
Caldas et al. (Mol. Immunol. May 2003; 39 (15): 941-952).
Winkler et al. (J. Immunol. Oct. 15, 2000; 165 (8): 4505-4514).
Vajdos et al. (J. Mol. Biol. Jul. 5, 2002; 320 (2): 415-428).
Stancovski et al. (Proceedings of the National Academy of Science USA. 1991; 88: 8691-8695).
Xu et al. (Int. J. Cancer. 1993; 53: 401-408).
Jiang et al. (J. Biol. Chem. Feb. 11, 2005; 280 (6): 4656-4662).
Boyer et al. (Int. J. Cancer. 1999; 82: 525-531).
Press et al. (J. Immunol. Dec. 15, 1988; 141 (12): 4410-4417).
Bettler et al. (Proc. Natl. Acad. Sci. USA. Sep. 1989; 86 (18): 7118-7122).
Riemer et al. (Mol. Immunol. 2005; 42: 1121-1124).
Pettersen et al. (J. Immunol. Jun. 15, 1999; 162 (12): 7031-7040).
Bernard et al. (Human Immunol. 1986; 17: 388-405).
De Pascalis et al. (J. Immunol. 2002; 169 (6): 3076-3084).
Wu et al. (J. Mol. Biol. Nov. 19, 1999; 294 (1): 151-162).
Casset et al. (Biochem. Biophys. Res. Commun. Jul. 18, 2003; 307 (1): 198-205).
MacCallum et al. (J. Mol. Biol. Oct. 11, 1996; 262 (5): 732-745).
Holm et al. (Mol. Immunol. Feb. 2007; 44 (6): 1075-1084).
George et al. (Circulation. 1998; 97: 900-906).
Greenspan et al. (Nature Biotechnology. 1999; 7: 936-937).
Ware (Immunol. Rev. Jun. 2008; 223: 186-201).

Affiliated with

Also associated with

Rating

Antibodies that specifically bind to TL5 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies that specifically bind to TL5, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that specifically bind to TL5 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4101000